Alpha Tau (DRTS): Company Cash Funds

Graphic logo of Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Ltd. is accelerating product launches through alliances with radiology centers, leveraging a staff of Israeli nuclear physicists. The company's cash flow dynamics demonstrate capital management, where the value of 0.10 represents the current metric. However, expansion is complicated by pressure from manufacturers of standard radiological equipment who are creating compact alternatives for clinics.

Company Cash Funds: Alpha Tau (DRTS) for 04/28/2023 - 11/21/2026

DRTS (Alpha Tau): analytical breakdowns and indicator data

- stock quotes and analyst forecast:
Analysis of all company metrics:Alpha Tau Corp
Brand item of Alpha Tau Medical Ltd

Alpha Tau Medical Ltd. holds a leading position in the development of high-precision alpha-radiation for oncology therapy. By analyzing the company's cash reserves, one can assess its ability to fund costly R&D projects without debt refinancing. This metric measures the liquid safety cushion, determining the business's resilience to market volatility and prolonged crises. A stable cash balance confirms the fundamental long-term viability of the innovative startup.